RSS Feed For (NASDAQ:GENZ)

GENZYME (NASDAQ:GENZ)

50.05 +0.42 (0.85%)
GENZYME (NASDAQ:GENZ) Delayed :
Previous Close $49.63    52 Week High $73.75 
Open $49.42    52 Week Low $47.09 
Day High $50.26    P/E 28.60 
Day Low $48.77    EPS $1.75 
Volume 2,974,330       
More GENZ Info: Chart SEC Filings Profile Historical Options

Genzyme Corp. Summary

Genzyme Corporation operates as a biotechnology company in the United States, European Union, Latin America, and Asia Pacific and operates through the five segments of Renal, Therapeutics, Transplant, Biosurgery, and Genetics.

Executives

Henri A. Termeer - Chairman, CEO

Links

http://www.genzyme.com

What is this?Friends, Peers and Foes

Ticker # Stories Ticker # Stories
AMGN 11 BIIB 10
GILD 10 ISIS 10
LIFE 6 PLX 6
WFC 5 BMRN 5
NE 4 STJ 4
STEM 4 ACTC 4
View All Friends, Peers and Foes

StreetInsider Reports on GENZ by Category

Comments on recent GENZ articles

Ken
on Nov 19, 2009
at 10:11 AM
PLX Why is this stock down over the last week?
Article: Protalix BioThera (PLX) May Have a Winner with Gaucher Drug prGCD
Iki
on Sep 2, 2009
at 05:15 PM
$10 is under esstimation !! Would like to emphsize that the holders can easily get more than $1B for FDA approved company, while $1B represent $13 of 76MM outstanding stocks. Profesionals can tell that the holder will not give up the company for much more...
Article: Hapoalim Securities Initiates Coverage on Protalix BioTherapeutics (PLX) with an Outperform; Attractive Entry Point
Charlie
on Jun 5, 2009
at 07:39 AM
Relational Investors Discloses Hidden Stakes in Plantronics (PLAB) ... PLAB = Photronics (not Plantronics)
Article: Relational Investors Discloses Hidden Stakes in Plantronics (PLAB), Burlington Northern (BNI), Genzyme (GENZ) and Zebra Tech (ZBRA)
Hedgie
on Mar 20, 2009
at 03:23 PM
Biomarin and Genzyme It makes a lot of sense for Genzyme to acquire Biomarin, but this has been obvious for a long time, and Genzyme has chosen not to bite. Also, Biomarin's management may not be interested in selling even at the thirty dollar level.
Article: Baird Said a Genzyme (GENZ) Takeover Of BioMarin (BMRN) Makes Sense To Them
sharifal@yahoo.com
on Jan 23, 2009
at 07:09 PM
Mozobil May I have some amount of drug for research purpose?
Article: Genzyme's (GENZ) Mozobil Receives FDA Approval

Comments on GENZ


No comments are currently available.